您当前的位置：
首页 >
文章列表页 >
Clinical observation of cadonilimab plus chemotherapy in advanced gastric adenocarcinoma or adenocarcinoma of gastroesophageal junction with intermediate， low， or no HER2 expression
更新时间：2026-07-28

    • Clinical observation of cadonilimab plus chemotherapy in advanced gastric adenocarcinoma or adenocarcinoma of gastroesophageal junction with intermediate， low， or no HER2 expression

    • ZHONGGUO YAOFANG   Vol. 37, Issue 14, Pages: 1868-1873(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.14.12    

      CLC： R969.4;R979.5

    • Received：04 March 2026，

      Revised：2026-06-18，

      Accepted：19 June 2026，

      Online First：24 July 2026，

      Published：30 July 2026

    移动端阅览

  • ZHU Ping,LI Xiaofei,ZHU Jia,et al.Clinical observation of cadonilimab plus chemotherapy in advanced gastric adenocarcinoma or adenocarcinoma of gastroesophageal junction with intermediate， low， or no HER2 expression[J].ZHONGGUO YAOFANG,2026,37(14):1868-1873. DOI： 10.6039/j.issn.1001-0408.2026.14.12.

  •  
  •  

0

Views

1

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Design and management scheme practice of intelligent drug shelf positioning software based on the “five-level positioning” concept
Mechanism of Qingre antai decoction in improving pregnancy outcomes of threatened abortion rats with blood heat syndrome based on JAK2/STAT3 and PI3K/AKT dual signaling pathways
Evidence-based expert consensus on the clinical application and pharmaceutical management of antibody-based drugs for the treatment of myasthenia gravis
Meta-analysis of the effects of different doses of vitamin D supplementation on maternal and infant outcomes in vitamin D-deficient pregnant women
Study on the mechanism of Euphorbia hirta L.-derived exosome-like nanovesicles regulating Nrf2/HO-1/NQO1 pathway to improve acetaminophen-induced liver injury

Related Author

No data

Related Institution

No data
0